Effect of LRIG1 on cell proliferation of glioma cell line U251

GUO Zhen-tao,LIU Bao-hui,DENG Gang,TIAN Dao-feng,ZHANG Shen-qi,CHEN Qian-xue
DOI: https://doi.org/10.3969/j.issn.1009-153X.2013.10.012
2013-01-01
Abstract:ObjectiveTo investigate the effect of leucine-rich repeats and immunoglobulin-like domains protein 1(LRIG1)on cell proliferation of glioma cell line U251.MethodsThe plasmids with LRIG1,LRIG1 siRNA,Bcl-2 or glial cell line-derived neurotrophic factor(GDNF)were constructed and then transfected into the U251 cells,respectively.The cell activities were detected by cell counting kit-8(CCK-8)assay.The expressions of Bcl-2,topoisomeraseⅡ(topoⅡ),GDNF and LRIG1 were detected by western blotting.ResultsThe plasmids with LRIG1,LRIG1 siRNA,Bcl-2 or GDNF were successfully constructed and transfected into U251cells.The cell activities significantly decreased in LRIG1-transfected U251 cells compared with those without(P<0.05).The expressions of Bcl-2,topoⅡand GDNF significantly decreased in LRIG1-transfected U251 cells compared with those without(P<0.05),but the expressions of Bcl-2,topoⅡand GDNF significantly increased in LRIG1 siRNA-transfected U251 cells compared with those without(P<0.05).The expression of LRIG1 significantly decreased in Bcl-2-or GDNF-transfected U251 cells compared with those without(P<0.05).ConclusionsThe LRIGl can significantly inhibit cell proliferation of glioma cell line U251 cells.It may be by negatively regulating expressions of Bcl-2,topoⅡand GDNF.
What problem does this paper attempt to address?